2023 presented challenges for the pharmaceutical market, such as rising inflation to government-led drug price cap negotiations, and waning demand for COVID-19…
Miramar Resources Limited (ASX:M2R, “Miramar” or “the Company”) advises that a review of historical drilling data has revealed potentially very significant magnetite…